Chloe Khoo is an Ophthalmology physician. OpenAlex indexes 30 publications with 880 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6400 Fannin Street
18th Floor
Houston, TX 770305389
Telephone
713-559-5200Provider last certified this registry record 24 Oct 2022.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202519 payments
- Apellis Pharmaceuticals, Inc.Program year20254 payments
- Genentech USA, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
98.3%Antineovascularisation agents81.1%Faricimab-svoa100%Part B, office-administered≥34 patientsComplement Inhibitor15.2%Avacincaptad pegol100%Part B, office-administered≥14 patients+ 3 more classes in this area
Cancer & immunology
1.4%Vascular Endothelial Growth Factor Inhibitor1.4%Aflibercept100%Part B, office-administered≥20 patientsMusculoskeletal
0.3%Cyclooxygenase Inhibitor0.3%Ketorolac Tromethamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Estimating Patient Demand for Ophthalmologists in the United States using Google Trends2021
- Racial differences in outcomes of retinal detachment repair following pars plana vitrectomy in the postoperative period: A TriNetX Analysis2021
- Racial Differences in Outcomes of Full Thickness Macular Hole Repair following Pars Plana Vitrectomy
Investigative Ophthalmology & Visual Science
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”